Takeda Pharmaceutical Company's total assets for Q4 2022 were $13.96T, an increase of 3.35% from the previous quarter. TAK total liabilities were $9.28T for the fiscal quarter, a 26.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.